NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

NIAID strategic plan details COVID-19 research priorities

Urgent public health measures are needed to control the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes, coronavirus disease 2019, or COVID-19. Scientific research to improve our understanding of the ...

Diseases, Conditions, Syndromes

New coronavirus stable for hours on surfaces: study

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists ...

HIV & AIDS

Newer anti-HIV drugs safest, most effective during pregnancy

The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available during pregnancy, researchers announced ...

Diseases, Conditions, Syndromes

COVID-19 a reminder of the challenge of emerging infectious diseases

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, ...

Diseases, Conditions, Syndromes

NIH clinical trial of remdesivir to treat COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University ...

Diseases, Conditions, Syndromes

Remdesivir prevents MERS coronavirus disease in monkeys

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists. ...

Diseases, Conditions, Syndromes

Recent advances in addressing tuberculosis give hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the ...

page 10 from 40